MedTrace Logo

Efficacy of Milk Product Supplemented With Bioactives in Lowering Post Meal Glucose Response

NCT05570435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2025-06-27

No results posted yet for this study

Summary

This is a monocentric, randomized controlled, open-label, 2x2 cross-over study. The main objective of the study is to Evaluate the efficacy of Nestle YIYANG TangLv milk powder in lowering the Post Prandial Glucose Response (PPGR) of a high carbohydrate meal when consumed with the meal.

Conditions

Interventions

BIOLOGICAL

Blood collection

Blood collection for glucose, insulin, GLP-1, GIP and C-peptide.

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    collaborator OTHER

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Wei Chen · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-16
Primary Completion
2023-03-14
Completion
2023-03-14

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05570435 on ClinicalTrials.gov